India’s pharmaceutical exports rebounded strongly in FY24 with a 10% rise, reaching $27.9 billion. The growth was powered by U.S. and EU demand, aided by global recognition of Indian generics and supportive government initiatives. Here's what this means for the future of Indian pharma.
